The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

The following is a summary of “Reducing time delays and enhancing reperfusion eligibility related to stroke suspicion by the ...

The ambulance would be the latest addition to Florida’s first mobile stroke treatment unit network, which speeds care to ...

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Stroke is the fifth-leading cause of death nationwide. Brain damage from strokes can be minimized if they are treated ...

A Gering teenager is on the road to recovery after a life-threatening ATV accident and subsequent stroke, thanks to the swift ...

For patients with acute ischemic stroke whose symptoms began 4.5 to 24 hours earlier, alteplase is associated with a higher percentage of patients achieving a score of 0 or 1 on the modified Rankin ...

Every year, millions of people die from stroke. In order to win against this disease which occurs the moment when a blood ...

Some people living with chronic stress have a higher risk of stroke, according to a study published on March 5, 2025, online in Neurology®, the medical journal of the American Academy of Neurology.

The lawsuit said Kristina Dukes was arrested for public intoxication minutes after she was discharged from a hospital where ...

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...

A smoke alarm and a stroke of luck might be credited for keeping a small fire at a Joplin tire shop from spreading.